HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $694,751 | +70433.1% | 6,755 | -25.2% | 0.00% | -25.0% |
Q1 2023 | $985 | -91.5% | 9,035 | -91.2% | 0.00% | -93.1% |
Q4 2022 | $11,617 | -91.9% | 102,104 | +4314.4% | 0.06% | +5700.0% |
Q3 2022 | $143,000 | -53.7% | 2,313 | -40.6% | 0.00% | -50.0% |
Q2 2022 | $309,000 | +40.5% | 3,892 | +85.1% | 0.00% | +100.0% |
Q1 2022 | $220,000 | +511.1% | 2,103 | +511.3% | 0.00% | – |
Q4 2021 | $36,000 | +24.1% | 344 | +22.4% | 0.00% | – |
Q3 2021 | $29,000 | -64.6% | 281 | -68.4% | 0.00% | – |
Q2 2021 | $82,000 | -10.9% | 890 | -11.5% | 0.00% | -100.0% |
Q1 2021 | $92,000 | -50.0% | 1,006 | -60.2% | 0.00% | 0.0% |
Q4 2020 | $184,000 | -5.6% | 2,527 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $195,000 | +364.3% | 2,527 | +238.3% | 0.00% | – |
Q2 2020 | $42,000 | +55.6% | 747 | -16.9% | 0.00% | – |
Q1 2020 | $27,000 | -18.2% | 899 | 0.0% | 0.00% | – |
Q4 2019 | $33,000 | +43.5% | 899 | +6.3% | 0.00% | – |
Q3 2019 | $23,000 | +4.5% | 846 | -6.3% | 0.00% | – |
Q2 2019 | $22,000 | – | 903 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |